| Role |
Name |
Disclosure |
Details |
| Author | Robyn Gmyrek, MD, Assistant Clinical Professor, Department of Dermatology, New York Presbyterian Hospital, Columbia University | Nothing to disclose | Details | | Coauthor | Maurice Dahdah MD, Clinical Fellow, Department of Dermatology, New York Presbyterian Hospital | Nothing to disclose | Details | | Medical Editor | Désirée Ratner, MD, Director of Dermatologic Surgery, George Henry Fox Assistant Clinical Professor, Department of Dermatology, Columbia Presbyterian Medical Center, New York Presbyterian Hospital | Nothing to disclose | Details | | Pharmacy Editor | David F Butler, MD, Professor of Dermatology, Texas A&M University College of Medicine; Director, Division of Dermatology, Scott and White Clinic; Director Dermatology Residency Training Program, Scott and White Clinic | 3M Pharmaceutical Graceway Pharmaceuticals | Details | | Managing Editor | John G Albertini, MD, Consulting Staff, Dermatologic Surgery, The Skin Surgery Center | Nothing to disclose | Details | | CME Editor | Catherine Quirk, MD, Clinical Assistant Professor, Department of Dermatology, Brown University | Nothing to disclose | Details | | Chief Editor | Dirk M Elston, MD, Director, Department of Dermatology, Geisinger Medical Center | Nothing to disclose | Details |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Robyn Gmyrek, Author |
The contributor discloses no conflict of interest. |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Maurice Dahdah, Coauthor |
The contributor discloses no conflict of interest. |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| John G Albertini, Managing Editor |
The contributor discloses no conflict of interest. |
|